OrthoPediatrics Posts 25-Cent Q3 Loss Per Share
KIDS sits 65% above its 52-week low of $14.42.
Summary
OrthoPediatrics reported a third-quarter loss of $5.93M, or 25 cents per share, on revenue of $72.7M, and increased its 2026 financial guidance. The earlier headline carried no revenue figure, no comparison to consensus, and no guidance update, so the size of any miss or beat was not yet known; the release now supplies the revenue line and the raised outlook. Context matters here: Q2 was a clean beat with revenue of $70.5M against $68.25M consensus and raised full-year guidance, so a Q3 loss print alone does not establish a deterioration. The stock trades near $23.82 on a small-cap base, which makes the full release — revenue, adjusted EBITDA, and any guidance revision — the deciding factor rather than the EPS line. Watch the complete Q3 release and the updated 2026 outlook for the actual read.
At the time of this announcement, KIDS was trading at $23.82 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $621.9M. The 52-week trading range was $14.42 to $26.74. This news item was assessed with positive market sentiment and an importance score of 7 out of 10. Source: Dow Jones Newswires.